At Two Labs, when we complete an OOP Cost Analysis, we seek to answer a number of key questions:
- What is the expected per-patient OOP cost in each channel (commercial and federal)?
- What percentage of patients will seek financial assistance in the commercial and Medicare channel (i.e. 501(c)(3))?
- What is the expected investment from a copay/financial assistance program for the commercial channel?
- What is the difference in investment between reimbursement programs?
Once we get answers, we can begin modeling different reimbursement strategies to find the optimal strategy for your drug, both in terms of market access and revenue.